CHILDRENS ACETAMINOPHEN- acetaminophen elixir 
Rij Pharmaceutical Corporation

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

CHILDRENS ACETAMINOPHEN

Active ingredient (in each 5 mL = 1 teaspoonful)

Acetaminophen 160 mg

Active ingredient (in each 5 mL = 1 teaspoonful)

Acetaminophen 160 mg

Purpose

Pain Reliever/Fever Reducer

Uses

temporarily:

Warnings

Liver warning

This product contains acetaminophen.

Severe liver damage may occur if your child takes

  • more than 5 doses in 24 hours, which is the maximum daily amount
  • with other drugs containing acetaminophen

Sore throat warning:

if sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.

Do not use

  • with any other drug containing acetaminophen (prescription or non-prescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
  • if your child is allergic to acetaminophen or any of the inactive ingredients in this product

Ask a doctor before use if your child has liver disease

Ask a doctor or pharmacist before use if your child is taking the blood thinning drug warfarin

When using this product do not exceed recommended dose (see overdose warning)

Stop use and ask a doctor if

  • new symptoms occur
  • redness or swelling is present
  • pain gets worse or lasts more than 5 days
  • fever gets worse or lasts more than 3 days

These could be signs of a serious condition.

Keep out of reach of children.

Overdose warning

Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical even if you do not notice any signs or symptoms.

Directions

Weight (lbs.)Age (yrs.)Dose (tsp or mL)
under 24under 2ask a doctor
24-352-3 years1 tsp or 5 mL
36-474-5 years1½ tsp or 7.5 mL
48-596-8 years2 tsp or 10 mL
60-719-10 years2½ tsp or 12.5 mL
72-9511 years3 tsp or 15 mL

Other information

Store at room temperature 15º - 30ºC (59º - 86ºF)
Protect from Freezing.
Protect from Light.
each teaspoon (5 mL) contains: sodium 7 mg
TAMPER EVIDENT: DO NOT USE THIS PRODUCT IF PRINTED INNER CAP SEAL IS BROKEN OR MISSING

Inactive ingredients

citric acid, FD&C red # 40, flavor, glycerin. polyethylene glycol, sodium benzoate, sodium citrate, sodium saccharin, sorbitol, water.

PRINCIPAL DISPLAY PANEL

Principal Display Panel

CHILDRENS ACETAMINOPHEN 
acetaminophen elixir
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:53807-129
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Acetaminophen (UNII: 362O9ITL9D) (acetaminophen - UNII:362O9ITL9D) Acetaminophen160 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
SODIUM CITRATE (UNII: 1Q73Q2JULR)  
SACCHARIN SODIUM (UNII: SB8ZUX40TY)  
SORBITOL (UNII: 506T60A25R)  
WATER (UNII: 059QF0KO0R)  
Product Characteristics
ColorREDScore    
ShapeSize
FlavorCHERRY (CHERRY) Imprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:53807-129-3030 mL in 1 BOTTLE; Type 0: Not a Combination Product03/16/1999
2NDC:53807-129-6060 mL in 1 BOTTLE; Type 0: Not a Combination Product03/16/1999
3NDC:53807-129-04118 mL in 1 BOTTLE; Type 0: Not a Combination Product03/16/1999
4NDC:53807-129-08236 mL in 1 BOTTLE; Type 0: Not a Combination Product03/16/1999
5NDC:53807-129-16473 mL in 1 BOTTLE; Type 0: Not a Combination Product03/16/1999
6NDC:53807-129-283785 mL in 1 BOTTLE; Type 0: Not a Combination Product03/16/1999
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart34303/16/1999
Labeler - Rij Pharmaceutical Corporation (144679156)
Establishment
NameAddressID/FEIBusiness Operations
Rij Pharmaceutical Corporation144679156manufacture(53807-129)

Revised: 4/2018
Document Id: a332408b-6d43-4198-99a7-26c51dda1fcb
Set id: ccc6389b-e9ed-47c2-930c-66ebf0110b0f
Version: 2
Effective Time: 20180430
 
Rij Pharmaceutical Corporation